Tuesday, 2 November 2021

Leishmaniasis infection among the migrant population of Europe: a systematic review Dr Melanie Etti, St. George’s University of London, UK

Epidemiology of Visceral Leishmaniasis in Kenya, June-December 2020 Dr Paul Kibati, Ministry of Health, Kenya

The utility of the Loop-Mediated Isothermal Amplification Assay for Monitoring Anti-leishmanial Treatment Efficacy in visceral leishmaniasis Dawit Gebreegzabher Hagos, Mekelle University, Ethiopia

The Translational Prospective of secretory proteins of Mycobacterium tuberculosis encapsulated in Bio-polymeric nanoparticles: An Interplay of Immune Response Dr Ramendra Pati Pandey, SRM University, India

Development of a Tropically Stable, Novel Oral Formulation of Amphotericin B to Treat Visceral Leishmaniasis Dr Kishor M. Wasan, University of British Columbia, Canada

Wednesday, 3 November 2021

Building capacity for Immunological Research and flow cytometry expertise in Uganda Alice Bayiyana, Makerere University, Uganda

Multiplexed qPCR panels to differentiate clinically relevant Leishmania species utilising bisulphite conversion technology Ineka Gow, University of Technology Sydney, Australia

Analysis of changes in mitochondrial membrane potential after Photodynamic Therapy in Leishmania promastigotes Luciana Maria Cortez Marcolino, University of Vale of Paraiba, Brazil

Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin Aschalew Tamiru, University of Gondar Leishmaniasis Research and Treatment Center, Ethiopia

Loop-Mediated Isothermal Amplification Assay for the Diagnosis of Leishmaniasis Dawit Gebreegzabher Hagos, Mekelle University College of Health Sciences, Ethiopia

Soluble adenylate cyclase of Leishmania donovani (LdHemAC) induced cyclic AMP upregulates Nrf2 mediated Heme oxygenase-1 expression promotes its intra-macrophages survival against oxidative stress Manjay Kumar, ICMR-RMRIMS, India